425: Strive & Semler Scientific Merger Communication

Strive, Inc. filed a Form 425 communication regarding its proposed business combination with Semler Scientific, Inc., including cautionary forward-looking statements.

Summary

• Strive, Inc. filed a Form 425 related to its proposed business combination with Semler Scientific, Inc.
• The communication was reposted on X.com by Pierre Rochard, a Board Member of Strive, Inc., on November 10, 2025.
• The filing includes a cautionary statement regarding forward-looking statements, outlining inherent risks and uncertainties related to the merger.
• It advises investors and stockholders to read the Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus for important information.
• Strive will issue additional shares of its Class A common stock in connection with the proposed transaction.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily serving as a procedural announcement and a comprehensive list of risks associated with a proposed merger. While it mentions potential benefits, the extensive cautionary statements balance the sentiment.

Positives

• The proposed transaction aims for strategic and financial benefits for the combined company.
• The combined company intends to implement Bitcoin treasury strategies.

Risks

• The occurrence of any event, change, or circumstance that could give rise to the right of one or both companies to terminate the merger agreement.
• The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The possibility that the anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
• Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, laws and regulations, and their enforcement could impact the transaction.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other unknown or unpredictable factors could harm Strive, Semler Scientific, or the combined company's results.

Future Outlook

The companies anticipate strategic and financial benefits from the proposed transaction, including the expected impact on the combined company's future financial performance and the ability to successfully integrate the businesses. They also plan to implement Bitcoin treasury strategies. However, these forward-looking statements are subject to significant risks and uncertainties.

Management Comments

• Pierre Rochard, Board Member of Strive, Inc., reposted the communication on X.com on November 10, 2025.

Industry Context

This announcement is specific to the proposed merger between Strive and Semler Scientific. It highlights a trend of companies exploring or adopting Bitcoin treasury strategies, which could represent a significant strategic shift for Semler Scientific, a medical device company, if the merger proceeds and Strive's strategy is implemented.

Legal Proceedings

• The possibility of legal proceedings being instituted against Strive or Semler Scientific or the combined company is listed as a risk.

Stakeholder Impact

• Potential adverse reactions of Strive's or Semler Scientific's customers.
• Changes to business or employee relationships.
• Dilution for Strive's existing shareholders due to the issuance of additional shares.

Next Steps

• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific.
• Stockholders of Semler Scientific will be asked to approve the proposed transaction.
• Strive and Semler Scientific may file other relevant documents concerning the proposed transaction with the SEC.

Key Dates

Keywords

Strive Inc, Semler Scientific, Merger, Acquisition, Business Combination, SEC Filing, Form 425, Bitcoin Treasury, Corporate Governance, Forward-Looking Statements, Risk Factors